The Food and Drug Administration (FDA) recently alleged that the Indiana Lions Eye Bank accepted donors who either had a sepsis diagnosis or showed clinical signs of sepsis, raising concerns within the organ-transplant industry. According to the FDA, five donors were identified under these conditions. In response, the Indiana Lions Eye Bank maintained that blood cultures from all five donors tested negative for the infection, asserting that “there is still only one gold standard for the diagnosis of sepsis, and that is a positive blood culture.” More details can be found in the original article here.